BioToxTech Co News
News
0
Ticker
086040.KQ
ISIN
KR7086040003
Actualités Eulerpool BioToxTech Co
Actualités de l'action BioToxTech Co
BioToxTech Co est suivi par de nombreux journalistes et investisseurs dans le monde. Nous rassemblons ici les dernières actualités concernant BioToxTech Co.
Communiqués de presse relatifs à l'action BioToxTech Co
BioToxTech Co publie régulièrement sur son site web des communiqués pertinents pour les investisseurs.
BioToxTech Co News 2026
Cette page contient toutes les actualités actuelles, analyses et communiqués de presse pour l'action BioToxTech Co (086040.KQ, ISIN : KR7086040003). Cela inclut les actualités Eulerpool, les analyses d'entreprise et les communiqués de presse officiels. Les données sont mises à jour régulièrement pour fournir aux investisseurs un aperçu complet des derniers développements chez BioToxTech Co.
BioToxTech Co Action
BioToxTech Co Biotoxtech Co., Ltd. generates revenue through non-clinical drug trials, offering safety evaluation research, efficacy evaluation research, and analysis research services. Safety evaluation includes general toxicity, local toxicity, reproductive and development, genotoxicity, immunotoxicity, carcinogenicity, safety pharmacology, ecotoxicology, histopathology, and hematology tests. Efficacy evaluation covers medical supplies, health supplements, and cosmetics. Analysis research provides pharmacokinetics (PK) and toxicokinetics (TK) tests, validation, and bio analysis services. The company serves clients requiring preclinical testing for pharmaceuticals, health products, and cosmetics. The firm expanded its operations by acquiring a 60% stake in a newly established subsidiary on March 13, 2013. This strategic move enhances its capacity to deliver comprehensive research services. Clients include pharmaceutical companies, health supplement manufacturers, and cosmetic brands seeking regulatory compliance and product safety validation before market entry. Biotoxtech's service portfolio targets the pharmaceutical, health supplement, and cosmetic industries. Its safety and efficacy testing ensures products meet regulatory standards, supporting clients in developing safe and effective formulations. The company's analysis research further aids in optimizing drug delivery and performance through PK and TK assessments.